OrderlyMeds Review: Compounded GLP-1 Care On One Monthly Fee

One charge a month, medication included

One flat monthly charge with the medicine inside it is the whole pitch at OrderlyMeds, a cash-pay telehealth service built around compounded GLP-1 weight loss treatment. The entry point is $149 a month (standard semaglutide rate; $74/mo promotional starter), while the compounded tirzepatide track bills at a flat 299 dollars a month, so the drug is not a second line item stacked on top of a membership fee. That structure suits people paying out of pocket who want one predictable number, since nothing here runs through insurance. Two facts deserve weight before you subscribe: the medicines are compounded, so they are not FDA-approved products, and the company appears in the FDA warning letter database with a 2026 letter. The promotional starter rate also steps up to the standard rate, so price your second year rather than your first month.

What the monthly fee buys, and what bills on top

The billing model is a straight monthly subscription. You pay one recurring amount, and the compounded medication forms part of that amount instead of arriving as a separate pharmacy charge. Many weight loss platforms split this in two, charging a care fee and then invoicing the drug, which makes real comparison hard.

Bundling helps a cash payer in a simple way. You get one figure to hold against other services, and dose changes do not automatically read as a new invoice. The catch is visibility: when medicine and care share one price, you cannot see what the clinical side actually costs, so it is worth asking what happens to the fee if you pause treatment for a month.

The starter rate and the step-up

New patients are quoted a promotional rate for compounded semaglutide, and that rate later becomes the standard rate: standard semaglutide rate; $74/mo promotional starter. Treat the standard figure as your true cost and the starter figure as a trial. A promotional rate that expires is not a discount you keep, and a year of treatment priced off the starter number will understate what you spend by a wide margin.

Before you enter card details, get two things in writing from the care team: the exact date the starter rate ends, and the amount billed on the first cycle after it ends.

Compounded tirzepatide at a flat rate

The second track bills 299 dollars a month for compounded tirzepatide, again with medication included. It sits above the semaglutide rate, which is expected, since brand tirzepatide is the more expensive molecule at retail. Both tracks are cash pay. OrderlyMeds does not bill insurance, so deductibles, prior authorization and pharmacy benefit tiers never enter the picture, and none of your spending counts toward a plan.

Costs the subscription does not settle

• Lab work. Baseline bloods such as A1c, kidney function and thyroid history review are routine practice in weight medicine, and a subscription that includes the drug does not necessarily include the panel. Ask who orders and pays.
• Shipping and cold-chain handling. Confirm whether delivery is inside the monthly amount for both tracks.
• Brand-name medicine. This is a compounded service, so a switch to an FDA-approved product means leaving the subscription and paying separately.
• Dose escalation. Ask whether moving up the ladder changes the monthly amount or the vial size you receive.
• Syringes, needles and sharps disposal, if not stated as included in your shipment.

A flat rate makes the twelve month arithmetic easy, and the twelve month number is the one that changes minds.

Our free cost calculators also let you test what happens when the starter rate ends part-way through the year.

The compounded semaglutide track

How semaglutide works

Semaglutide is a GLP-1 receptor agonist, an incretin-based medicine that mimics a gut hormone released after eating. It slows stomach emptying, reduces appetite signalling in the brain and improves the body’s insulin response. In the FDA-approved weight management formulation, it is a once-weekly injection used alongside diet and activity changes, not instead of them.

The trial record behind the approved molecule is strong. In the 68 week STEP 1 trial, adults taking once-weekly semaglutide 2.4 mg with lifestyle support lost roughly 15 percent of body weight on average, far more than placebo (peer-reviewed trial report). Those results came from the approved product, not from a compounded copy, and results with compounded preparations have not been studied the same way.

The titration ladder, and why the chart matters

Dose escalation is the part patients most often get wrong on their own. The approved weight management schedule for semaglutide starts at 0.25 mg once weekly for four weeks, then steps to 0.5 mg, 1 mg, 1.7 mg and finally 2.4 mg, with roughly four weeks at each step. The slow climb exists to limit nausea and vomiting, not to delay results.

Compounded vials complicate this. They are often dosed in units drawn from a multi-dose vial rather than in a pre-set pen click, and the FDA has flagged dosing errors, including patients drawing many times the intended amount, among its concerns about unapproved GLP-1 products (FDA safety information). If you take this track, ask for a written titration plan that states milligrams and the matching unit measurement for the concentration you are sent, and keep it beside the vial.

Quick tip: photograph your vial label and your written dose plan together, so a pharmacist or urgent care clinician can read both if you ever need help.

Side effects, warnings and who should avoid it

Nausea, vomiting, diarrhoea, constipation, stomach pain, burping and fatigue are the common effects, and they cluster around dose increases. Serious risks named on the approved labelling include pancreatitis, gallbladder disease including gallstones, kidney injury from dehydration caused by severe vomiting, allergic reactions and, in people with type 2 diabetes, worsening of diabetic retinopathy.

Semaglutide carries a boxed warning for thyroid C-cell tumours seen in rodent studies, and it should not be used by anyone with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (official prescribing information summary). It is not for use in pregnancy, and it raises hypoglycaemia risk when combined with insulin or a sulfonylurea. Because these medicines slow stomach emptying, tell any anaesthetist about them before a planned procedure. New severe abdominal pain, persistent vomiting or signs of an allergic reaction are reasons to seek care the same day.

Who the semaglutide track suits

This track fits a cash payer who wants injectable GLP-1 treatment at a predictable monthly amount, who has no thyroid cancer history, no pancreatitis history and no plan-based coverage to fall back on. Weight medicine is normally considered at a body mass index of 30 or above, or 27 and above with a weight-related condition such as high blood pressure or sleep apnoea, and a clinician reviews the whole picture rather than a single figure (NIDDK patient guidance).

For the difference between compounded preparations and the approved products, see our compounded versus brand semaglutide breakdown.

The compounded tirzepatide track

Two hormones instead of one

Tirzepatide acts on both GLP-1 and GIP receptors, so it is described as a dual agonist rather than a single incretin mimic. It is also a once-weekly injection. In the 72 week SURMOUNT-1 trial of the approved product, average weight change reached about 21 percent at the highest dose studied (peer-reviewed trial report). The approved weight management ladder starts at 2.5 mg weekly for four weeks, moves to 5 mg, then rises in 2.5 mg steps at intervals of at least four weeks to a maximum of 15 mg weekly.

The Eli Lilly cease-and-desist, and supply risk

This track carries a business risk that the semaglutide track does not. OrderlyMeds has publicly stated that it received a cease-and-desist letter from Eli Lilly on April 1, 2025 regarding compounded tirzepatide, and published a response on April 11, 2025 (company statement carried by Yahoo Finance). Compounded copies of a patented drug depend on regulatory and legal conditions that can change, and enforcement can interrupt supply with little notice.

The practical question is what happens to you mid-titration if shipments stop. Ask, in writing, whether the subscription pauses or refunds when a track is discontinued, and whether the care team will support a transition plan. That question is more urgent here because there is no Surescripts e-prescribing connection, so a prescription cannot simply be routed to your local pharmacy in an afternoon.

Safety points specific to this track

Tirzepatide shares the GLP-1 side effect profile: gastrointestinal effects dominate, and they concentrate at each dose step. It also carries a boxed warning for thyroid C-cell tumours and the same contraindication for personal or family history of medullary thyroid carcinoma or MEN 2. Pancreatitis, gallbladder problems, dehydration and hypoglycaemia in combination with insulin or a sulfonylurea all appear on the approved labelling. Anyone with a history of severe gastrointestinal disease, including gastroparesis, needs a clinician’s judgement before starting. Our tirzepatide dosing and side effects notes cover the escalation schedule in more detail.

Comparing the two OrderlyMeds tracks side by side

Signing up, step by step

Step 1: the intake questionnaire

Expect an online health history covering weight, current medications, thyroid and pancreatic history, diabetes status, pregnancy status and past GLP-1 use. Answer the thyroid cancer and pancreatitis questions carefully. They are the ones that decide whether this class is appropriate at all.

Step 2: check your state and your clinician

Telehealth prescribing requires a clinician licensed in the state where you are located, so confirm your ZIP code is served before you pay anything. Ask which type of clinician reviews your file and whether you can message that person later, or only a care team inbox.

Step 3: clinician review and the prescription decision

A prescription still depends on a licensed prescriber’s assessment. No online form removes that step, and any service implying otherwise would be a reason to walk away.

Step 4: choose a track and confirm the billing dates

Select semaglutide or tirzepatide, then note the starter rate end date, the standard rate that follows and the renewal date. Screenshot the checkout summary.

Step 5: first delivery and your dose plan

Compounded injectables ship from a compounding pharmacy. Before the first injection, confirm the concentration, the units that equal your prescribed milligram dose, storage instructions and who to contact if the vial arrives warm or damaged.

Step 6: ask which pharmacy filled it

The pharmacy that compounds your medicine is not named in the public marketing, which is a fair question to raise directly. Ask for the pharmacy name, the state it is licensed in and whether it is a 503A compounding pharmacy or a 503B outsourcing facility, since the two operate under different oversight rules. Keep the answer with your records.

The app, the portal and login

There are patient apps on both platforms. The Apple listing describes tracking recent orders and viewing a loyalty discount (Apple App Store listing), and the Google Play listing describes a patient portal used to complete check-ins, track orders, chat with the medical team and reach resources (Google Play listing).

Two apps and a portal is a better setup than an email-only workflow, because your dose history, check-ins and messages sit in one place you can open at a pharmacy counter. It also gives you a route in if the website is slow or unreachable: sign in through the app rather than assuming your account has gone. Keep your own copy of dose changes anyway, since app records belong to the platform and not to you.

Cancelling, and what happens to your refills

Cancellation is the part of any subscription that decides how much risk you carry, and the terms here are worth reading closely rather than assumed. Ask three questions before you subscribe: how notice is given, whether cancelling stops a shipment already in production, and whether any part of a paid month is refundable.

Practical steps that protect you regardless of the answers: cancel several days ahead of the renewal date rather than on it, do it through the app or portal so the request is timestamped, follow up in writing to the care team, and check your card statement on the next cycle. If a refund window exists, note the number of days and the trigger date. If you are stopping a GLP-1 rather than switching, expect appetite to return, and speak to a clinician about a plan for maintaining weight rather than simply ending shipments.

Support, refills and escalation

Refills run through the app, and the care-team chat is the main support channel described in the store listings. That works well for routine matters: a check-in, an order status question, a dose query between steps.

Escalation is the weaker area. No published response time commitment appears in the public material, so ask what happens on a weekend and what number to use for an urgent side effect. The absence of a Surescripts connection matters here too: if a compounded supply stops, or if you need a documented prescription history for another clinician, the transfer is a manual paperwork exercise rather than an electronic one. Request a copy of your visit notes and dose history early, not when you need them.

Privacy and what happens to your health data

A telehealth service that also runs a consumer app usually holds two kinds of information: clinical records created by clinicians, which sit under health privacy rules, and app or marketing data, which often does not. The distinction is where most surprises live, so read the privacy policy for the app and the service separately.

Four things to check before you upload photos, weights or medication history: what categories of data are collected, whether any of it is shared with advertising or analytics partners, how long records are kept after you cancel, and how you request deletion. The App Store privacy label is a quick way to see what the developer says it collects and whether it is linked to your identity. If a service will not answer a deletion question in writing, treat that as information about how it operates.

Is OrderlyMeds legit? Certification set against the FDA record

So, is OrderlyMeds legit in the ordinary sense of the word? The service is a real company with licensed clinician review, patient apps on both major stores and LegitScript certification, which is the merchant review programme that advertising platforms rely on to screen telehealth and pharmacy advertisers (LegitScript certification lookup). That is a meaningful signal and it separates the service from anonymous vial sellers with no clinician in the loop.

The record also contains an FDA warning letter dated 2026, published in the agency’s warning letter database (FDA warning letter). A warning letter is the agency stating that it has identified violations of federal law and expects correction. It is not a criminal charge and not automatically a product recall, but it is the strongest routine public signal the FDA sends short of enforcement action. Read it yourself, note what it addresses, and ask the company what changed in response.

Set beside that, the manufacturer cease-and-desist over compounded tirzepatide is a commercial dispute rather than a safety finding, but it bears on whether your treatment keeps arriving. Our provider scoring approach explains how regulatory records weigh against pricing and clinical detail.

Compounded GLP-1s: what you take on

Compounded medicines are mixed by a pharmacy rather than manufactured and reviewed by the FDA. The agency does not assess their safety, effectiveness or quality before they reach patients, and it has warned about unapproved GLP-1 products sold for weight loss, including products using salt forms that differ from the approved active ingredient and products sold without adequate dosing instructions. That guidance is worth reading in full before you start any compounded track.

None of this makes compounded treatment inherently unsafe, and pharmacies operating lawfully serve real clinical needs. It does mean the burden of checking shifts to you: the pharmacy’s identity and licence, the concentration in your vial, the written dose plan, and an agreed monitoring schedule with the clinician. If cost is what pushes you toward compounded medicine, it is worth pricing the approved products once as well, so the trade-off is a decision rather than an assumption.

Who this service suits, and who should look elsewhere

It works best for a self-pay patient with no GLP-1 coverage, who wants an injectable weight loss track at one predictable monthly amount, is comfortable with compounded medicine, and will actually use the app check-ins. Budgeting is genuinely simpler when the medication is not billed separately.

Look elsewhere if you want an FDA-approved product, if you have insurance that might cover weight medicine, if you have a thyroid cancer or MEN 2 history, if you are pregnant or planning pregnancy, or if a regulatory record is a threshold issue for you. Anyone who needs continuity across clinicians should also weigh the absence of electronic prescribing. Our GLP-1 telehealth comparison guide keeps the live rankings, and the weight loss telehealth directory is the wider list.

Questions to ask before you subscribe

• What is the exact standard monthly amount after the starter rate ends, and on what date does it change?
• Which compounding pharmacy fills my prescription, and is it a 503A or 503B facility?
• Does the monthly amount change as my dose increases?
• Who orders baseline labs, and what will they cost me?
• What are the cancellation notice period and the refund window?
• If compounded tirzepatide becomes unavailable, what happens to my subscription and my titration plan?
• Can I get a copy of my visit notes and dose history on request?

If you are switching from another service, ask your current provider for your records, your last dose and the date of your final shipment before you cancel, so there is no gap mid-titration. Run the twelve month totals for both before you move, using our free savings report as a starting point.

Reputation check

Public sentiment sits in a few identifiable places. There is a customer review profile for the service on Trustpilot, and written reviews on the Apple App Store and Google Play listings, where the discussion tends to centre on ordering, check-ins and care-team messaging rather than clinical outcomes. Reddit threads drive a large share of interest in the brand, mostly about tirzepatide pricing and what the rate becomes once the promotional period ends. Those posts are anecdote: they cannot confirm a price, a pharmacy or a policy, and they age quickly.

The attributable items carry more weight. LegitScript certification is checkable. The 2026 FDA warning letter is published by the agency. The Eli Lilly cease-and-desist is documented by the company’s own statement. Read those three, then treat the star ratings as texture rather than evidence. On our side, community reviews are moderated, incentivised reviews are labelled, and sponsored placement is labelled and never affects scores or rankings.

Authoritative sources

• FDA warning letter
• FDA safety communication on unapproved GLP-1 products
• LegitScript certification lookup
• Official prescribing information summary for semaglutide injection
• NIDDK guidance on prescription weight medicines
• STEP 1 semaglutide trial report
• SURMOUNT-1 tirzepatide trial report

Educational content, not medical advice. Always consult a qualified clinician before starting, stopping or switching treatment.